November 7, 2025
Andernach– LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company today announced the successful closing of its acquisition of Renaissance Lakewood, LLC (“Renaissance”), a US-based contract development and manufacturing organization (CDMO) specializing in nasal sprays and sterile dosage forms.
READ MORE READ MORE
October 13, 2025
Andernach– LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company today announces the acquisition of Renaissance Lakewood, LLC (“Renaissance”), a US-based contract development and manufacturing organization (CDMO) specializing in nasal sprays and sterile dosage forms.
READ MORE READ MORE
September 30, 2024
Renaissance Lakewood, LLC (“Renaissance”), a leading global contract development and manufacturing organization (“CDMO”) is proud to be manufacturing neffy®, which is now commercially available in the US.
READ MORE READ MORE
September 3, 2024
Renaissance Lakewood, LLC (“Renaissance”), a leading pharmaceutical contract development and manufacturing organization (CDMO), today announced the official opening of their new, 67,000 sq ft, expansive warehouse at their recently opened headquarters at 1215 Paco Way in Lakewood, NJ.
READ MORE READ MORE
October 20, 2021
Global CDMO invests more than $40 million in infrastructure, equipment, and technology for 370,000 sq.-ft state-of-the-art Ocean County, NJ campus
READ MORE READ MORE
October 18, 2021
A review of nasal spray formulation excipients and their potential for enhancing drug delivery
READ MORE READ MORE"*" indicates required fields